Eascra Biotech Names Andrew Goodearl Chief Scientific Officer
Eascra Biotech announced Andrew Goodearl, Ph.D., as chief scientific officer, adding an executive with biotherapeutics and genetic-medicine research experience to the early-stage nanomedicine company. The company did not identify a predecessor, appointment effective date,…
